After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other managed care insurers have largely bounced back.

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's expectations despite decreasing 51% year-over-year. | Elevance Health posted $418 million in profit for the fourth quarter of 2024,

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early trading Thursday, a day after after pulling to the edge of its all-time high set in early December.

(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted Elevance's shares more than 5% before the bell and also boosted peers such as Cigna and CVS Health.

The Indianapolis-based company said it had net income of $1.81 per share. Earnings, adjusted for one-time gains and costs, came to $3.84 per share. The results beat Wall Street expectations. The average estimate of 17 analysts surveyed by Zacks Investment Research was for earnings of $3.80 per share.

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%. It is anticipated ...

Here is how Elevance Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Benefit Expense Ratio: 92.4% versus the 15 ...

Elevance Health led the insurance sector higher after it beat Wall Street’s sales and profit targets and raised its dividend. Elevance rose 5.5% before the bell, followed by Cigna, which rose 3.8% and UnitedHealth Group which gained 1.6%. CVS Health inched up 1.3%.

Elevance Health Inc. closed 28.53% short of its 52-week high of $567.26, which the company achieved on September 3rd.

StockNews.com cut shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a hold rating in a research note issued to investors on Monday morning. Several other research firms also recently weighed in on ELV.